Atilla Ertan

ORCID: 0000-0002-0246-666X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Esophageal Cancer Research and Treatment
  • Eosinophilic Esophagitis
  • Esophageal and GI Pathology
  • Gastric Cancer Management and Outcomes
  • Neuropeptides and Animal Physiology
  • Gastrointestinal disorders and treatments
  • Helicobacter pylori-related gastroenterology studies
  • Inflammatory Bowel Disease
  • Gastroesophageal reflux and treatments
  • Pancreatitis Pathology and Treatment
  • Gallbladder and Bile Duct Disorders
  • Neuroendocrine Tumor Research Advances
  • Microscopic Colitis
  • Receptor Mechanisms and Signaling
  • Gastrointestinal Tumor Research and Treatment
  • Pancreatic and Hepatic Oncology Research
  • Genetic factors in colorectal cancer
  • Gastrointestinal Bleeding Diagnosis and Treatment
  • Biliary and Gastrointestinal Fistulas
  • Metastasis and carcinoma case studies
  • Digestive system and related health
  • Diverticular Disease and Complications
  • Abdominal Trauma and Injuries
  • Pediatric Hepatobiliary Diseases and Treatments
  • Peptidase Inhibition and Analysis

Memorial Hermann
2014-2023

The University of Texas Health Science Center at Houston
2013-2023

Hacettepe University
2008-2018

Rhode Island Hospital
2017-2018

University of Rochester Medical Center
2018

Providence College
2018

Tokyo Metropolitan Geriatric Hospital
2018

Baylor University Medical Center
2018

Brown University
2017

The University of Texas MD Anderson Cancer Center
2000-2017

AbstractBackground: The incidence of esophageal adenocarcinoma in White males has been reported to be increasing. aims this study were determine: 1) the trends carcinoma United States with an emphasis on histologic type, sex, and ethnicity, 2) whether increase stage IV tumors can confirmed, 3) survival factors affecting survival. Methods: Data from SEER program National Cancer Institute submission dates 1973-98 used. Hispanics available for analysis only years 1992-98. Statistical was...

10.1080/003655202762671215 article EN Scandinavian Journal of Gastroenterology 2002-01-01

Acute renal failure (ARF) is rarely reported after bowel preparation with sodium phosphate. We report a patient mild Crohn disease (in remission), without history of disease, and normal baseline function, who developed ARF 14 days for colonoscopy oral A biopsy showed multifocal calcium phosphate deposition in the tubules against background diffuse chronic tubulointerstitial injury. Review literature suggested 2 distinct patterns context cleansing. One pattern characterized by ARF, which...

10.1043/1543-2165(2006)130[101:rfanaw]2.0.co;2 article EN Archives of Pathology & Laboratory Medicine 2006-01-01

Abstract Acute renal failure (ARF) is rarely reported after bowel preparation with sodium phosphate. We report a patient mild Crohn disease (in remission), without history of disease, and normal baseline function, who developed ARF 14 days for colonoscopy oral A biopsy showed multifocal calcium phosphate deposition in the tubules against background diffuse chronic tubulointerstitial injury. Review literature suggested 2 distinct patterns context cleansing. One pattern characterized by ARF,...

10.5858/2006-130-101-rfanaw article EN Archives of Pathology & Laboratory Medicine 2006-01-01

AIM:To compare effectiveness, safety, and cost of photodynamic therapy (PDT) radiofrequency ablation (RFA) in treatment Barrett's dysplasia (BD). METHODS:Consecutive case series patients undergoing either PDT or RFA at single center by a investigator were compared.Thirty-three with high-grade (HGD) had porfimer sodium photosensitzer 630 nm laser (130 J/cm), maximum 3 sessions.Fifty-three BD (47 low-grade -LGD, 6 HGD) step-wise circumferential focal using the HALO system

10.3748/wjg.v19.i41.7106 article EN cc-by-nc World Journal of Gastroenterology 2013-01-01
Séverine Vermeire Péter L. Lakatos Timothy E. Ritter Stephen B. Hanauer Brian Bressler and 95 more Reena Khanna Kim L. Isaacs Saumin Shah Alysha Kadva Helen E.J. Tyrrell Young S. Oh Swati Tole Akiko Chai Jennifer Pulley Christopher Eden Wenhui Zhang Brian G. Feagan Philip Abraham Mauro Acir Crippa Júnior Humberto Aguilar Tasneem Ahmed I Altorjay Vibeke Andersen Ronen Arai Hays Arnold Karlee Ausk Jeffrey Axler Kamran Ayub Avinash Balekuduru Guerino Barbalaco Neto Isaac Bassan Brian W. Behm Pradeep Bekal Shobna Bhatia Barnabás Bod Carlos Eduardo Brandão‐Mello Julia Brandeburova Johannes Breedt Brian Bressler Ivan V. Chopey Michael Connor Richard Corlin Carlos Alejandro Cortez Hernandez Arijit De Alexander de Sá Rolim Sandra Di Felice Boratto Tyler Dixon D. Poli D Dresner George Aaron Du Vall Matthias Ebert Robert Ehehalt Atilla Ertan R Valencia Jason Etzel Jan Fallingborg Brian G. Feagan Miroslav Fedurco Enrique Castro Valéria Ferreira de Almeida e Borges Mark Finklestein Andreas Fischer Mark R. Fleisher Angel Ricardo Flores Rendon Ronald Fogel Osvaldo Franceschi Curtis Freedland David Gatof Kanwar R. Gill Henning Glerup Vardaraj Gokak Eran Goldin Hector Alejandro Gomez Jaramillo Nitin Gupta Z Gurzó Olga Gyrina Mohammed Aejaz Habeeb Stephen Hanauer Robert Hardi William R. Harlan Ammar Hemaidan Melvin Heyman Péter Hoffmann William Holderman Frank Holtkamp-Endemann Gyula Horvat Kim L. Isaacs Eran Israeli Sender Jankiel Miszputen Søren Kejser Jensen Kenneth P. Johnson Jennifer Jones Osvaldo Da Silva Júnior Barbora Kadleckova Mukesh Kalla Zsuzsanna Kallo N C Karyotakis Lior H. Katz Leo Katz Nirmal Kaur

10.1016/s2468-1253(21)00295-8 article EN ˜The œLancet. Gastroenterology & hepatology 2021-11-17

Pituitary adenylate cyclase-activating polypeptide (PACAP) is a new member of the secretin/glucagon peptides family, being most homologous to vasoactive intestinal peptide (VIP). The present study was designed investigate possible effect PACAP on rat gastrointestinal smooth muscle in vitro. We demonstrated that 1) reduced basal smooth-muscle contractions all portions tract, but VIP region-specific. inhibitory midcolon approximately 100 times greater than VIP. 2) significantly inhibited...

10.3109/00365529209000091 article EN Scandinavian Journal of Gastroenterology 1992-01-01

The purpose of this study was to determine prospectively whether p53 protein accumulation in biopsies Barrett's metaplasia (BM) is a predictor malignant progression, without relying on dysplasia grading.Sections formalin-fixed paraffin-embedded tissue from the initial 275 patients with BM, who had no high-grade (HGD) or oesophageal adenocarcinoma (EAC), were stained for by immunohistochemistry. mean follow-up 41 months. p53-positive divided into four groups: scattered positive cells,...

10.1111/his.13193 article EN Histopathology 2017-02-22

ABSTRACT Aim This in vitro study evaluated the effect of different cavity disinfection agents on bond strength a silorane-based resin composite. Materials and methods Thirty-six caries-free human third mandibular molars sectioned mesio-distal direction were mounted acrylic with their flat dentin surfaces exposed. After wet ground # 600 silicon carbide paper, teeth randomly divided into 6 groups 12 each according to agents; chlorhexidine (CHX); sodium hypochlorite (NaOCl), propolis, ozone,...

10.5005/jp-journals-10024-1047 article EN The Journal of Contemporary Dental Practice 2011-01-01

Abstract Context.—For a confident diagnosis of dysplasia in Barrett metaplasia, the epithelial atypia should also involve surface epithelium. However, pathologists are often faced with biopsies where crypts show dysplasia, but epithelium is either uninvolved or unevaluable. We previously grouped these cases indefinite for (IND). Objective.—To determine clinical significance IND grading metaplasia. Design.—All from 276 prospectively followed patients who did not have high-grade (HGD)...

10.5858/2010-0097-oa.1 article EN Archives of Pathology & Laboratory Medicine 2011-04-01

Summary In this paper a series of 60 cases ulcerative colitis seen since 1960 at the Department Gastroenterology University Ankara School Medicine is presented. Symptomatology, clinical courses and complications disease in Turkish are discussed.

10.1007/bf02617689 article EN Diseases of the Colon & Rectum 1970-01-01

Although esophageal adenocarcinomas (EADCA) have been shown to substantially reduced or absent Fas expression, the status of ligand (FasL) in these tumors, especially adenocarcinomas, is largely unknown.Using immunohistochemistry, authors investigated FasL expression sections formalin fixed, paraffin embedded tissue from 13 EADCA. They also studied 15 squamous cell carcinomas (ESCCA) and lymph node metastases 7 EADCA 4 ESCCA. The percentage positive cells each tumor was recorded. compared...

10.1002/(sici)1097-0142(20000201)88:3<524::aid-cncr5>3.0.co;2-u article EN Cancer 2000-02-01
Coming Soon ...